Table 5.
Survival of patients according to first line chemotherapy
| |
Median overall survival |
|---|---|
| Time in months (95% CI) | |
| Cisplatin + taxanes (N = 46) |
14.2 (10.8-19.6) |
| Carboplatin + taxanes (N = 69) |
10.5 (7.6-13.1) |
| Platinum without taxanes (N = 28) |
11.2 (8.6-25.3) |
| Other chemotherapy (N = 48) |
5.6 (4.3-8.1) |
| Clinical trials testing not approved regimens (N = 7) | 5.7 (1.7 – NR) |
NR = Non Reached.